Contact ACell
Phone: (800) 826-2926
Fax: (410) 715-4511
info@acell.com
From the article: Unanimous Federal Appeals Court Decision in ACell's Patent Victory Over Cook Biotech and Purdue Research Foundation. Read more... (PDF file)
From the article: Federal Appeals Court denies Cook Biotech's and Purdue Research Foundation's petition for rehearing in ACell's victory on patent infringement. Read more... (PDF file)
From the article: A three judge panel of the Court of Appeals for the Federal Circuit, which specializes in patent cases, unanimously reversed a July 2005 finding of patent infringement, holding instead that ACell's product does not infringe Purdue's patent. Read more... (PDF file)
From the article: Stem cell therapy works well, but this process works just as well and doesn't involve having to collect tissue to get the stem cells, augment them and put them back into the horse. Read more... (PDF file)
From the article: Liko, a four-year-old male Tursiops truncatus sustained a severe traumatic wound at the cranial junction of the dorsal fin and dorsal body wall. The severity and location of the wound as well as its propensity for reinjury necessitated intervention. As an alternative to partial amputation of the cranial 1/3 of the dorsal fin, a novel surgical reconstruction was performed utilizing ACell extra cellular matrix. Read more... (PDF File)
From the article: All ACell Vet™ UBM products, regardless of form (sheet, granule, powder, gel) are medical devices and are manufactured in the United States under a Quality Management System that is based on the FDA's Good Manufacturing Practices (21 CFR Part 820). Use of the ACell Vet™ UBM products in veterinary treatments according to the product instructions is fully compliant with U.S. FDA laws and regulations. Read more... (PDF File)